Louis Brenner

Corporate Officer/Principal at

Harvard University

56 year

Health Technology

Consumer Services

Profile

Louis Brenner is currently a Lecturer at Harvard University.
Formerly, Dr. Brenner was President, Chief Executive Officer & Director at Hopewell Therapeutics, Inc. from 2022 to 2024, and held the same titles at Allena Pharmaceuticals, Inc. from 2019 to 2022.
Other former roles include Chief Medical Officer & Senior Vice President at Idera Pharmaceuticals, Inc. (2014-2015), Chief Medical Officer & Senior Vice President at Radius Health, Inc. (2012-2014), Senior Vice President at AMAG Pharmaceuticals, Inc. (2006-2010), Senior Director-Business Development-Renal Unit at Genzyme Corp.
(2002-2006), and Director positions at PLC Medical Systems, Inc. and Goldfinch Bio, Inc. Education includes a doctorate from Duke University (1996), an undergraduate degree from Yale University (1992), and an MBA from Harvard Business School (2002).

Louis Brenner active positions

Companies	Position	Start
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

All active positions of Louis Brenner

Former positions of Louis Brenner

Companies	Position	End
Hopewell Therapeutics, Inc. Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Develops novel synthetic lipid based nanoparticles for nucleic acid delivery for gene therapy & gene editing	Chief Executive Officer	2024-05-31
ALLENA PHARMACEUTICALS, INC.	Chief Executive Officer	2022-09-01
Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications	Chief Tech/Sci/R&D Officer	2015-03-31
RADIUS HEALTH, INC.	Chief Tech/Sci/R&D Officer	2014-01-01
AMAG PHARMACEUTICALS, INC.	Corporate Officer/Principal	2010-11-30

See the detail of Louis Brenner's experience

Training of Louis Brenner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Louis Brenner's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications	Health Technology
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
Radius Health, Inc. Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics	Health Technology
Duke University Duke University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Yale University Yale University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
PLC Medical Systems, Inc. PLC Medical Systems, Inc. Medical SpecialtiesHealth Technology Manufactures and wholesales medical devices	Health Technology
Allena Pharmaceuticals, Inc. Allena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and retails drugs through online	Health Technology
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Goldfinch Bio, Inc. Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Develop medicines and therapies for patients with kidney disease	Health Technology
Hopewell Therapeutics, Inc. Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Develops novel synthetic lipid based nanoparticles for nucleic acid delivery for gene therapy & gene editing	Health Technology